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Despite the improvement in mental health care that has
occurred in the last decades, the mortality risk in
patients with schizophrenia has not been changed, and
there was even an increase in the mortality of these
patients when compared to the general population. The
main causes for this increased mortality are somatic dis-
eases, especially diabetes, hypercholesterolemia, hyper-
trygliceridemia, cardiovascular diseases (including
arterial hypertension), obesity, HIV infection/AIDS,
hepatitis C and osteoporosis [1]. The link between sec-
ond generation antipsychotics and cardiovascular risk
factors has raised questions on their overall safety, and
these concerns are even more important if patients are
on compulsory treatment. Furthermore, at least half of
patients suffering from schizophrenia have one co-
morbidity not diagnosed or wrongly diagnosed [2]. In a
sample of 476 community patients suffering from schi-
zophrenia, we found rates of diagnosed hypertension of
6,9%, hypercholesterolemia of 9,0%, hypertrigliceridemia
of 6,3%, and diabetes of 4,2%. Not only these figures are
lower than in other large studies, but also apparently
only 12 to 30% of the patients presenting these disorders
were being treated for these conditions [3]. Barriers to
recognition and management of physical diseases in
patients with schizophrenia are related both to health
care providers and to patient/disease. Acute admission
could be a target for the screening and treatment of
these disorders, and we tried to find a screening proto-
col for this situation. Acutely ill patients have higher
rates of infections and liver abnormalities, but lower
rates of hypercholesterolemia [4]. In our sample more
than 80% of patients with schizophrenia are retired or
unemployed. Resources are scarce, and their allocation
to these patients can prevent the access of people suffer-
ing from other disorders to the care they need.
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